Efficacy News and Research

RSS
Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Pharmacyclics first quarter GAAP net loss increases to $14.5M

Pharmacyclics first quarter GAAP net loss increases to $14.5M

KYTHERA presents long-term results from ATX-101 Phase 2 study at ASDS 2011

KYTHERA presents long-term results from ATX-101 Phase 2 study at ASDS 2011

Positive top-line results from NPSP558 Phase 3 study on hypoparathyroidism

Positive top-line results from NPSP558 Phase 3 study on hypoparathyroidism

UCB to sponsor several key sets of Cimzia data on RA at ACR 2011 meeting

UCB to sponsor several key sets of Cimzia data on RA at ACR 2011 meeting

New data from Novartis' ACZ885 Phase III study on SJIA

New data from Novartis' ACZ885 Phase III study on SJIA

Psychological stress can trigger flares of vasculitis

Psychological stress can trigger flares of vasculitis

Chemical breakthrough could simplify drug development process

Chemical breakthrough could simplify drug development process

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Novel technique could help avoid wrong-level thoracic spine surgery

Novel technique could help avoid wrong-level thoracic spine surgery

Presidio Pharmaceuticals advances with its HCV antiviral drug discovery, development programs

Presidio Pharmaceuticals advances with its HCV antiviral drug discovery, development programs

International research explains why measles virus spreads so quickly

International research explains why measles virus spreads so quickly

Phase III study of BG-12 in relapsing-remitting multiple sclerosis sparks excitement

Phase III study of BG-12 in relapsing-remitting multiple sclerosis sparks excitement

Chemotherapy plus radiation improves overall survival for patients with stage II NPC

Chemotherapy plus radiation improves overall survival for patients with stage II NPC

Janssen receives FDA approval for Xarelto to prevent stroke in people with AF

Janssen receives FDA approval for Xarelto to prevent stroke in people with AF

Rexahn announces results from Serdaxin Phase IIb trial on major depressive disorder

Rexahn announces results from Serdaxin Phase IIb trial on major depressive disorder

Positive data from RegeneRx RGN-259 Phase 2 trial on dry eye syndrome

Positive data from RegeneRx RGN-259 Phase 2 trial on dry eye syndrome

GTx third quarter net loss increases to $9.3 million

GTx third quarter net loss increases to $9.3 million

Positive results from Clinuvel's US Phase II study of photoprotective drug, afamelanotide

Positive results from Clinuvel's US Phase II study of photoprotective drug, afamelanotide

Abbott to highlight latest research findings on HUMIRA at ACR annual meeting

Abbott to highlight latest research findings on HUMIRA at ACR annual meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.